Showing results (21-30 of 97) with videos related to
Sort By:
Pageof 10
Medical Oncology (Northwood, London, England)|May 1, 2017
Progress and challenges in the treatment of small cell lung cancerAlfredo Tartarone, Pasqualina Giordano, Rosa Lerose, et al.Oncotargets and Therapy|December 28, 2018
Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223Giandomenico Roviello, Rosj Gallicchio, Giovanni Bozza, et al.Investigational New Drugs|October 23, 2018
Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisoneGiandomenico Roviello, Roberto Petrioli, Alberto Bonetta, et al.Anti-Cancer Drugs|July 16, 2019
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxelGiandomenico Roviello, Silvia P Corona, Andrea G Multari, et al.Lung Cancer (Amsterdam, Netherlands)|June 25, 2016
Possible applications of circulating tumor cells in patients with non small cell lung cancerAlfredo Tartarone, Elisabetta Rossi, Rosa Lerose, et al.Dermatology Reports|April 4, 2022
Therapeutic management of a symptomatic Kaposi's sarcoma patient with renal failure undergoing haemodialysis: A case reportAnna Passarelli, Giovanna Galdo, Teresa Pellegrino, et al.Medical Oncology (Northwood, London, England)|July 10, 2012
Identification of a new insertion in exon 20 of EGFR in a woman with NSCLCAngela Zupa, Giulia Vita, Matteo Landriscina, et al.Medicine|July 3, 2019
Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?Giandomenico Roviello, Silvia Paola Corona, Raffaele Conca, et al.Journal of Thoracic Disease|November 30, 2017
Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancerAlfredo Tartarone, Rosa Lerose, Maria Grazia Rodriquenz, et al.Medicine|May 17, 2018
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II studyGiandomenico Roviello, Roberto Petrioli, Valerio Nardone, et al.Pageof 10